Publications


2020

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, Auvinen P, Beckmann MW, Beesley J, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Blot W, et al.


Nat Commun.
202001
https://pubmed.ncbi.nlm.nih.gov/31949161

Inclusion of endogenous plasma dehydroepiandrosterone sulphate and mammographic density in risk prediction models for breast cancer.

Gabrielson M, Ubhayaseker KA, Acharya SR, Andersson Franko M, Eriksson M, Bergquist J, Czene K,Hall P.


Cancer Epidemiol Biomarkers Prev.
202001
https://pubmed.ncbi.nlm.nih.gov/31948996

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghoussaini M, Moradi Marjaneh M, et al.


Nat Genet.
202001
https://pubmed.ncbi.nlm.nih.gov/31911677

2019

The impact of alcohol consumption and physical activity on breast cancer: the role of breast cancer risk.

Rainey L, Eriksson M, Trinh T, Czene K, Broeders MJM, van der Waal D, Hall P.


Int J Cancer.
201912
https://pubmed.ncbi.nlm.nih.gov/31863475

CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer.

He W, Grassmann F, Eriksson M, Eliasson E, Margolin S, Thorén L, Hall P, Czene K.


J Clin Oncol.
201912
https://pubmed.ncbi.nlm.nih.gov/31800347

Interval breast cancer is associated with other types of tumors.

Grassmann F, He W, Eriksson M, Gabrielson M, Hall P, Czene K.


Nat Commun.
201910
https://pubmed.ncbi.nlm.nih.gov/31641120

Association of Microcalcification Clusters with Short-term Invasive Breast Cancer Risk and Breast Cancer Risk Factors.

Alsheh Ali M, Czene K, Hall P, Humphreys K.


Sci Rep.
201910
https://pubmed.ncbi.nlm.nih.gov/31601987

Women’s perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.

Rainey L, Jervaeus A, Donnelly LS, Evans DG, Hammarström M, Hall P, Wengström Y, Broeders MJM, van der Waal D.


Psychooncology
201905
https://www.ncbi.nlm.nih.gov/pubmed/30848018

Does three-dimensional functional infrared imaging improve breast cancer detection based on digital mammography in women with dense breasts?

Hellgren RJ, Sundbom AE, Czene K, Izhaky D, Hall P, Dickman PW.


Eur Radiol.
201905
https://www.ncbi.nlm.nih.gov/pubmed/31115623

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.

Vachon CM, Scott CG, Tamimi RM, Thompson DJ, Fasching PA, Stone J, et al.


Breast Cancer Res.
201905
https://www.ncbi.nlm.nih.gov/pubmed/31118087

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

Ferreira MA, Gamazon ER, Al-Ejeh F, Aittomäki K, Andrulis IL, Anton-Culver H, et al.


Nat Commun.
201904
https://www.ncbi.nlm.nih.gov/pubmed/30988301

Detection of potential microcalcification clusters using multivendor for-presentation digital mammograms for short-term breast cancer risk estimation.

Alsheh Ali M, Eriksson M, Czene K, Hall P, Humphreys K.


Med Phys.
201904
https://www.ncbi.nlm.nih.gov/pubmed/30801718

Comparison of self-reported and register-based hospital medical data on comorbidities in women.

Ho PJ, Tan CS, Shawon SR, Eriksson M, Lim LY, Miao H, Png E, Chia KS, Hartman M, Ludvigsson JF, Czene K, Hall P, Li J.


Sci Rep.
201903
https://www.ncbi.nlm.nih.gov/pubmed/30837593

Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.

Strell C, Paulsson J, Jin SB, Tobin NP, Mezheyeuski A, Roswall P, Mutgan C, Mitsios N, Johansson H, Wickberg SM, Svedlund J, Nilsson M, Hall P, Mulder J, Radisky DC, Pietras K, Bergh J, Lendahl U, Wärnberg F, Östman A.


J Natl Cancer Inst.
201902
https://www.ncbi.nlm.nih.gov/pubmed/30816935

Detection of Potential Microcalcification Clusters Using Multi Vendor For-presentation Digital Mammograms for Short-term Breast Cancer Risk estimation.

Alsheh Ali M, Eriksson M, Czene K, Hall P, Humphreys K.


Med Phys.
201902
https://pubmed.ncbi.nlm.nih.gov/30801718

Genome-wide association study of germline variants and breast cancer-specific mortality.

Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, et al.


Br J Cancer.
201902
https://www.ncbi.nlm.nih.gov/pubmed/30787463

Determinants of Mammographic Density Change.

Azam S, Sjölander A, Eriksson M, Gabrielson M, Czene K, Hall P.


JNCI Cancer Spectr.
201902
https://www.ncbi.nlm.nih.gov/pubmed/31360892

Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.

He W, Eriksson L, Törnberg S, Strand F, Hall P, Czene K.


BMC Med.
201901
https://pubmed.ncbi.nlm.nih.gov/30700300

Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer.

Eriksson L, He W, Eriksson M, Humphreys K, Bergh J, Hall P, Czene K.


JNCI Cancer Spectr.
201901
https://www.ncbi.nlm.nih.gov/pubmed/31360886

Shared heritability and functional enrichment across six solid cancers.

Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, et al.


Nat Commun.
201901
https://www.ncbi.nlm.nih.gov/pubmed/30683880